Indivior Pharmaceuticals, Inc. (INDV)
40.82
+0.82
(+2.06%)
USD |
NASDAQ |
Jul 07, 16:00
40.82
0.00 (0.00%)
After-Hours: 18:05
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.979B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 159.5% |
| Valuation | |
| PE Ratio | 20.67 |
| PE Ratio (Forward) | |
| PS Ratio | 4.023 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -3.535 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 96.00% |
Profile
| Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA. |
| URL | http://www.indivior.com |
| Investor Relations URL | N/A |
| HQ State/Province | Virginia |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Core |
| Next Earnings Release | Aug. 06, 2026 (est.) |
| Last Earnings Release | Apr. 30, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 16, 2016 |
Profile
| Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA. |
| URL | http://www.indivior.com |
| Investor Relations URL | N/A |
| HQ State/Province | Virginia |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Core |
| Next Earnings Release | Aug. 06, 2026 (est.) |
| Last Earnings Release | Apr. 30, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 16, 2016 |